Literature DB >> 2884255

Role of interleukin 2 (IL 2) and hemopoietin-1 (H-1) in the generation of mouse natural killer (NK) cells from primitive bone marrow precursors.

G Migliorati, L Cannarile, R B Herberman, A Bartocci, E R Stanley, C Riccardi.   

Abstract

The development of natural killer (NK) cells from bone marrow (BM) precursors was studied. Recombinant interleukin 2 (IL 2) was able to induce the in vitro development of NK cells when added to cultures of mouse BM cells. Treatment of donor mice with 5-fluorouracil (150 mg/kg i.v.), which eliminates more differentiated cells but spares less differentiated cells, appears to augment NK cell development. The "NK stem cell" was found to be asialo GM1-, Thy-1+, Lyt-2-, and Lyt-1-. The cells generated in vitro had a typical phenotype of NK cells, being asialo GM1+, Lyt-5+, Thy-1+, Lyt-2-, and Lyt-1-. These effector cells also had specificity characteristics of NK cells lysing the NK-susceptible YAC-1 and K562 targets, but not the NK-resistant EL/4 or allogeneic and syngeneic blasts. Hemopoietin-1 (H-1), a factor which acts on very primitive multipotent BM cells, was able to cooperate with IL 2, increasing the development of NK cells. In contrast, other factors such as interleukin 3 or colony-stimulating factor did not cause induction of NK activity when added to cultures of BM cells, indicating that this effect, i.e., induction of NK cell development, is peculiar to IL 2. These results indicate that IL 2 can act as a differentiation as well as growth factor for NK cells, and that H-1 can promote the development of functional activity in a lymphocyte subpopulation as well as affect the differentiation of myelomonocytic and other cell lineages. This experimental system appears quite useful for characterization of BM precursors for NK cells, and should help to better understand the relationship of the NK cell lineage to the T cell or other lineages.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2884255

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Differential augmentation of in vivo natural killer cytotoxicity in normal primates with recombinant human interleukin-1 and granulocyte-macrophage colony-stimulating factor.

Authors:  T A Davis; R L Monroy; R R Skelly; R E Donahue; T J MacVittie
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

2.  Chemotherapy-induced modulation of natural killer and lymphokine-activated killer cell activity in euthymic and athymic mice.

Authors:  Z Gazit; E Kedar
Journal:  Cancer Immunol Immunother       Date:  1994-04       Impact factor: 6.968

3.  Effect of a glucan, sizofiran, on natural-killer activity of 5-fluorouracil-treated murine bone marrow cells.

Authors:  Y Tsuchiya; M Matsutani; M Inoue; S Sato; T Asano; M Yajima
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

Review 4.  Murine natural killer cell differentiation: past, present, and future.

Authors:  T A Moore; M Bennett; V Kumar
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

5.  Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2.

Authors:  M A Caligiuri; C Murray; M J Robertson; E Wang; K Cochran; C Cameron; P Schow; M E Ross; T R Klumpp; R J Soiffer
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

6.  Cooperative effects of colony-stimulating factor 1 and recombinant interleukin 2 on proliferation and induction of cytotoxicity of macrophage precursors generated from mouse bone marrow cell cultures.

Authors:  H Li; R Schwinzer; M Baccarini; M L Lohmann-Matthes
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

7.  Cyclosporin A inhibition of interleukin 2 gene expression, but not natural killer cell proliferation, after interferon induction in vivo.

Authors:  M T Kasaian; C A Biron
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

8.  Interleukin 2-induced proliferation of murine natural killer cells in vivo.

Authors:  C A Biron; H A Young; M T Kasaian
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

9.  Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function.

Authors:  R M Welsh; J O Brubaker; M Vargas-Cortes; C L O'Donnell
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

10.  The generation of natural killer (NK) cells from NK precursor cells in rat long-term bone marrow cultures.

Authors:  M R van den Brink; S S Boggs; R B Herberman; J C Hiserodt
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.